Novel QTLs for HDL levels identified in mice by controlling for Apoa2 allelic effects: Confirmation of a chromosome 6 locus in a congenic strain

Physiological Genomics

Volumn 17, Issue , 2004, Pages 48-59

  Welch, Carrie L ^a,e   Bretschger, Sara ^a   Wen, Ping Zi ^b   Mehrabian, Margarete ^b   Latib, Nashat ^a   Fruchart Najib, Jamila ^c   Fruchart, Jean Charles ^c   Myrick, Christy ^d   Lusis, Aldons J ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INSTITUT PASTEUR DE LILLE   (France)

^d UNIVERSITY OF FLORIDA   (United States)

^e Division of Molecular Genetics   (United States)

Author keywords

Atherosclerosis; Lipoprotein; Quantitative trait locus

Indexed keywords

APOLIPOPROTEIN A2; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; AMYLOIDOGENIC APOLIPOPROTEIN A II, MOUSE; AMYLOIDOGENIC APOLIPOPROTEIN A-II, MOUSE; CHOLESTEROL;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 6; CONGENIC STRAIN; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; LINKAGE ANALYSIS; MALE; MOUSE; MULTIFACTORIAL INHERITANCE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BREEDING; C57BL MOUSE; CHROMOSOME; CHROMOSOME MAP; GENETIC LINKAGE; GENETICS; HYPERCHOLESTEROLEMIA; METHODOLOGY; NONOBESE DIABETIC MOUSE;

ANIMALIA;

ALLELES; ANIMALS; APOLIPOPROTEIN A-II; BREEDING; CHOLESTEROL; CHOLESTEROL, HDL; CHROMOSOME MAPPING; CHROMOSOMES; FEMALE; HYPERCHOLESTEROLEMIA; LINKAGE (GENETICS); MICE; MICE, CONGENIC; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; MULTIFACTORIAL INHERITANCE; QUANTITATIVE TRAIT LOCI;

EID: 1842509761     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00124.2003     Document Type: Article

References (69)

1. Bailey DW. Genetics of histocompatibility in mice. Immunogenetics 2: 249-256, 1975.
2. Breslow J. Battling heart disease. Science 273: 15, 1996.
3. Brousseau T, Dupuy-Gorce AM, Evans A, Arveiler D, Ruidavets JB, Haas B, Cambou JP, Luc G, Ducimetiere P, Amouyel P, and Helbecque N. Significant impact of the highly informative (CA)n repeat polymorphism of the APOA-II gene on the plasma APOA-II concentrations and HDL subfractions: the ECTIM study. Am J Med Genet 110: 19-24, 2002.
4. Brown MS and Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340, 1997.
5. Bu X, Warden CH, Xia YR, De Meester C, Puppione DL, Teruya S, Lokensgard B, Daneshmand S, Brown J, Gray RJ, Rotter JI, and Lusis AJ. Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein loci. Hum Genet 93: 639-648, 1994.
6. Cases S, Smith SJ, Zheng YW, Myers HM, Lear SR, Sande E, Novak S, Collins C, Welch CB, Lusis AJ, Erickson SK, and Farese RV Jr. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci USA 95: 13018-13023, 1998.
7. Clee SM, Kastelein JJ, Van Dam M, Marcil M, Roomp K, Zwarts KY, Collins JA, Roelants R, Tamasawa N, Stulc T, Suda T, Ceska R, Boucher B, Rondeau C, DeSouich C, Brooks-Wilson A, Molhuizen HO, Frohlich J, Genest J Jr, and Hayden MR. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest 106: 1263-1270, 2000.
8. Copeland NG, Jenkins NA, Gilbert DJ, Eppig JT, Maltais LJ, Miller JC, Dietrich WF, Weaver A, Lincoln SE, Steen RG, Stein LD, Nadeau JH, and Lander ES. A genetic linkage map of the mouse: current applications and future prospects. Science 262: 57-66, 1993.
9. Couture P, Otvos JD, Cupples LA, Wilson PW, Schaefer EJ, and Ordovas JM. Association of the A-204C polymorphism in the cholesterol 7alpha-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study. J Lipid Res 40: 1883-1889, 1999.
10. Dammerman M and Breslow JL. Genetic basis of lipoprotein disorders. Circulation 91: 505-512, 1995.
11. Dansky HM, Shu P, Donavan M, Montagno J, Nagle DL, Smutko JS, Roy N, Whiteing S, Barrios J, McBride TJ, Smith JD, Duyk G, Breslow JL, and Moore KJ. A phenotype-sensitizing Apoe-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse. Genetics 160: 1599-1608, 2002.
12. Davignon J and Genest J Jr. Genetics of lipoprotein disorders. Endocrinol Metab Clin North Am 27: 521-550, 1998.
13. Dietrich W, Katz H, Lincoln SE, Shin HS, Friedman J, Dracopoli NC, and Lander ES. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131: 423-447, 1992.
14. Dietrich W, Miller J, Steen R, Merchant MA, Damron-Boles D, Husain Z, Dredge R, Daly MJ, Ingalls KA, O'Connor TJ, Evans CA, DeAngelis MM, Levinson DM, Kruglyak L, Goodman N, Copeland NG, Jenkins NA, Hawkins TL, Stein L, Page DC, and Lander ES. A comprehensive genetic map of the mouse genome. Nature 14: 149-152, 1996.
15. Doolittle MH, LeBoeuf RC, Warden CH, Bee LM, and Lusis AJ. A polymorphism affecting apolipoprotein AII translational efficiency determines high density lipoprotein size and composition. J Biol Chem 265: 10380-10388, 1990.
16. European Backcross Collaborative Group. Towards high resolution maps of the mouse and human genomes: a facility for ordering markers to 01 cM resolution. Hum Mol Genet 3: 621-627, 1994.
17. Frankel W. Taking stock of complex trait genetics in mice. Trends Genet 11: 471-477, 1995.
18. Garcia CK, Mues G, Liao Y, Hyatt T, Patil N, Cohen JC, and Hobbs HH. Sequence diversity in genes of lipid metabolism. Genome Res 11: 1043-1052, 2001.
19. Green MC et al. (Committee on Standardized Genetic Nomenclature for Mice). Standard karyotype of the mouse, Mus musculus. J Hered 63: 69-72, 1972.
20. Gu L, Johnson MW, and Lusis AJ. Quantitative trait locus analysis of plasma lipoprotein levels in an autoimmune mouse model: interactions between lipoprotein metabolism, autoimmune disease, and atherogenesis. Arterioscler Thromb Vasc Biol 19: 442-453, 1999.
21. Guerra R, Wang J, Grundy SM, and Cohen JC. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 94: 4532-4537, 1997.
22. Han Z, Heath SC, Shmulewitz D, Li W, Auerbach SB, Blundell ML, Lehner T, Ott J, Stoffel M, Friedman JM, and Breslow JL. Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia. Am J Med Genet 110: 234-242, 2002.
23. Hedrick CC, Castellani LW, Warden CH, Puppione DL, and Lusis AJ. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice. J Biol Chem 268: 20676-20682, 1993.
24. Hoeg JM. Lipoproteins and atherosclerosis. Endocrinol Metab Clin North Am 27: 569-584, 1998.
25. Hua X, Wu J, Goldstein JL, Brown MS, and Hobbs HH. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Genomics 25: 667-673, 1995.
26. Hwa JJ, Zollman S, Warden CH, Taylor BA, Edwards PA, Fogelman AM, and Lusis AJ. Genetic and dietary interactions in the regulation of HMG-CoA reductase gene expression. J Lipid Res 33: 711-725, 1992.
27. Juo SH, Beaty TH, Duffy DL, Coresh J, and Kwiterovich PO Jr. No common major gene for apolipoprotein A-I and HDL3-C levels: evidence from bivariate segregation analysis. Genet Epidemiol 16: 54-68, 1999.
28. Kamboh MI, Bunker CH, Aston CE, Nestlerode CS, McAllister AE, and Ukoli FA. Genetic association of five apolipoprotein polymorphisms with serum lipoprotein-lipid levels in African blacks. Genet Epidemiol 16: 205-222, 1999.
29. Ko C, Lee TL, Lau PW, Li J, Davis BT, Voyiaziakis E, Allison DB, Chua SC Jr, and Huang LS. Two novel quantitative trait loci on mouse chromosomes 6 and 4 independently and synergistically regulate plasma apoB levels. J Lipid Res 42: 844-855, 2001.
30. Lander ES and Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11: 241-247, 1995.
31. LeBoeuf RC, Puppione DL, Schumaker VN, and Lusis AJ. Genetic control of lipid transport in mice: structural properties and polymorphisms of plasma apolipoproteins. J Biol Chem 258: 5063-5070, 1983.
32. Lembertas AV, Perusse L, Chagnon YC, Fisler JS, Warden CH, Purcell-Huynh DA, Dionne FT, Gagnon J, Nadeau A, Lusis AJ, and Bouchard C. Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest 100: 1240-1247, 1997.
33. Levanon D, Hsieh CL, Francke U, Dawson PA, Ridgway ND, Brown MS, and Goldstein JL. cDNA cloning of human oxysterol-binding protein and localization of the gene to human chromosome 11 and mouse chromosome 19. Genomics 7: 65-74, 1990.
34. Love JM, Knight AM, McAleer MA, and Todd JA. Towards construction of a high-resolution map of the mouse genome using PCR-analyzed microsatellites. Nucleic Acids Res 18: 4123-4130, 1990.
35. Lusis AJ, Taylor BA, Wangenstein RW, and LeBoeuf RC. Genetic control of lipid transport in mice: genes controlling structure of high density lipoproteins. J Biol Chem 258: 5071-5078, 1983.
36. Lyons MA, Wittenburg H, Li R, Walsh KA, Churchill GA, Carey MC, and Paigen B. Quantitative trait loci that determine lipoprotein cholesterol levels in DBA/2J and CAST/Ei inbred mice. J Lipid Res 44: 953-967, 2003.
37. Machleder D, Ivandic B, Welch C, Castellani L, Reue K, and Lusis AJ. Complex genetic control of HDL levels in mice in response to an atherogenic diet: coordinate regulation of HDL levels and bile acid metabolism. J Clin Invest 99: 1406-1419, 1997.
38. Manly K. A Macintosh program for storage and analysis of experimental genetic mapping data. Mamm Genome 4: 303-313, 1993.
39. Manly K and Olson JM. Overview of QTL mapping software and introduction to Map Manager QT. Mamm Genome 10: 327-334, 1999.
40. Martin G, Duez H, Blanquart C, Berezowski V, Poulain P, Fruchart JC, Najib-Fruchart J, Glineur C, and Staels B. Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I. J Clin Invest 107: 1423-1432, 2001.
41. Mehrabian M, Callaway KA, Clarke CF, Tanaka RD, Greenspon M, Lusis AJ, Sparkes RS, Mohandas T, Edmond J, Fogelman AM, and Edwards PA. Regulation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A synthase and the chromosomal localization of the gene. J Biol Chem 261: 16249-16255, 1986.
42. Mehrabian M, Qiao JH, Hyman R, Ruddle D, Laughton C, and Lusis AJ. Influence of the ApoA-II gene locus on HDL levels and fatty streak development in mice. Arterioscler Thromb 13: 1-10, 1993.
43. Mehrabian M, Castellani LW, Wen PZ, Wong J, Rithaporn T, Hama SY, Hough GP, Johnson D, Albers JJ, Mottino GA, Frank JS, Navab M, Fogelman AM, and Lusis AJ. Genetic control of HDL levels and composition in an interspecific mouse cross (CAST/Ei X C57BL/6J). J Lipid Res 41: 1936-1946, 2000.
44. Miller CG, Lee TD, LeBoeuf RC, and Shively JE. Primary structure of apolipoprotein A-II from inbred mouse strain BALB/c. J Lipid Res 28: 311-319, 1987.
45. Morel L, Mohan C, Yu Y, Schiffenbauer J, Rudofsky UH, Tian N, Longmate JA, and Wakeland EK. Multiplex inheritance of component phenotypes in a murine model of lupus. Mamm Genome 10: 176-181, 1999.
46. Mouse Genome Database. Mouse Genome Informatics web site [Online]. Bar Harbor, ME: The Jackson Laboratory. http://www.informatics.jax.org/ (May 2003).
47. Pablos-Mendez A, Mayeux R, Ngai C, Shea S, and Berglund L. Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population. Arterioscler Thromb Vasc Biol 17: 3534-3541, 1997.
48. Paterson AH, Damon S, Hewitt JD, Zamir D, Rabinowitch HD, Lincoln SE, Lander ES, and Tanksley SD. Mendelian factors underlying quantitative traits in tomato: comparison across species, generations, and environments. Genetics 127: 181-197, 1991.
49. Piepho RW. The pharmacokinetics and pharmacodynamics of agents proven to raise high-density lipoprotein cholesterol. Am J Cardiol 86: 35L-40L, 2000.
50. Pitman WA, Korstanje R, Churchill GA, Nicodeme E, Albers JJ, Cheung MC, Staton MA, Sampson SS, Harris S, and Paigen B. Quantitative trait locus mapping of genes that regulate HDL cholesterol in SM/J and NZB/B1NJ inbred mice. Physiol Genomics 9: 93-102, 2002; 10.1152/physiolgenomics.00107.2001.
51. Purcell-Huynh DA, Weinreb A, Castellani LW, Mehrabian M, Doolittle MH, and Lusis AJ. Genetic factors in lipoprotein metabolism: Analysis of a genetic cross between inbred mouse strains NZB/B1NJ and SM/J using a complete linkage map approach. J Clin Invest 96: 1845-1858, 1995.
52. Reynolds GA, Basu SK, Osborne TF, Chin DJ, Gil G, Brown MS, Goldstein JL, and Luskey KL. HMG-CoA reductase: a negatively regulated gene with unusual promoter and 5′ untranslated regions. Cell 38: 275-285, 1984.
53. Roberts SB, MacLean CJ, Neale MC, Eaves LJ, and Kendler LS. Replication of linkage studies of complex traits: an examination of variation of location estimates. Am J Hum Genet 65: 876-884, 1999.
54. Rozzo SJ, Vyse TJ, Drake CG, and Kotzin BL. Effect of genetic background on the contribution of New Zealand Black loci to autoimmune lupus nephritis. Proc Natl Acad Sci USA 93: 15164-15168, 1996.
55. Scott J, Knott TJ, Priestley LM, Robertson ME, Mann DV, Kostner G, Miller GJ, and Miller NE. High-density lipoprotein composition is altered by a common DNA polymorphism adjacent to apoprotein AII gene in man. Lancet 1: 771-773, 1985.
56. Serreze DV, Bridgett M, Chapman HD, Chen E, Richard SD, and Leiter EH. Subcongenic analysis of the IddI3 locus in NOD/Lt mice: evidence for several susceptibility genes including a possible diabetogenic role for β2-microglobulin. J Immunol 160: 1472-1478, 1998.
57. Silver LM. Mouse Genetics. New York: Oxford University Press, 1995.
58. Srinivasan SR, Ehnholm C, Elkasabany A, and Berenson G. Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood to adulthood: the Bogalusa Heart Study. Atherosclerosis 143: 435-443, 1999.
59. Stoll M, Kwitek-Black AE, Cowley AW Jr, Harris EL, Harrap SB, Krieger JE, Printz MP, Provoost AP, Sassard J, and Jacob HJ. New target regions for human hypertension via comparative genomics. Genome Res 10: 473-482, 2000.
60. Sugiyama F, Churchill GA, Higgins DC, Johns C, Makaritsis KP, Gavras H, and Paigen B. Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. Genomics 71: 70-77, 2001.
61. Sullivan PM, Mezdour H, Aratani Y, Knouff C, Najib J, Reddick RL, Quarfordt SH, and Nobuyo N. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem 272: 17972-17980, 1997.
62. y mice. Biochim Biophys Acta 1453: 385-395, 1999.
63. Truett GE, Walker JA, Truett AA, Mynatt RL, Heeger P, and Warman M. Preparation of PCR-Quality DNA with Hot Sodium Hydroxide and Tris (HOTSHOT). Biotechniques 29: 52-54, 2000.
64. Wang J, Freeman DJ, Grundy SM, Levine DM, Guerra R, and Cohen JC. Linkage between cholesterol 7α-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J Clin Invest 101: 1283-1291, 1998.
65. Wang X and Paigen B. Quantitative trait loci and candidate genes regulating HDL cholesterol: a murine chromosome map. Arterioscler Thromb Vasc Biol 22: 1390-1401, 2002.
66. Weng W and Breslow JL. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc Natl Acad Sci USA 93: 14788-14794, 1996.
67. Wiltshire T, Pletcher MT, Batalov S, Barnes SW, Tarantino LM, Cooke MP, Wu H, Smylie K, Santrosyan A, Copeland NG, Jenkins NA, Kalush F, Mural RJ, Glynne RJ, Kay SA, Adams MD, and Fletcher CF. Genome-wide single-nucleotide polymorphism analysis defines haplotype patterns in mouse. Proc Natl Acad Sci USA 100: 3380-3385, 2003.
68. Wright FA, O'Connor DT, Roberts E, Kutey G, Barry CC, Yoneda LU, Timberlake D, and Schlager G. Genome scan for blood pressure loci in mice. Hypertension 34: 625-630, 1999.
69. Yui MA, Muralidharan K, Moreno-Altamirano B, Perrin G, Chestnut K, and Wakeland EK. Production of congenic mouse strains carrying NOD-derived diabetogenic genetic intervals: an approach for the genetic dissection of complex traits. Mamm Genome 7: 331-334, 1996.